Introduction {#S0001}
============

Pancreatic cancer (PC) is the third most common cause of cancer-related death, and most patients are diagnosed with metastasis due to lack of early symptoms and diagnostic techniques.[@CIT0001] Despite advances in the processes of surgery and chemotherapy, the mortality rate of PC is predicted to increase markedly.[@CIT0002] Given that only a minority of patients diagnosed with PC are eligible for surgical intervention, more and more research is gradually shifting towards identifying the molecular mechanisms of risk factors associated with PC promotion in order to facilitate the discovery of novel targets and agents.

In recent years, microRNA (miRNA) has become one of the main hotspots of research regarding the development and progression of cancer. As a post-transcriptional regulator of gene expression, miRNA is involved in many biological processes, including development, differentiation, proliferation and apoptosis of cells.[@CIT0003],[@CIT0004] Particular miRNAs function either as tumor suppressors or oncogenes, which leads to the abnormal activity of miRNA target genes in different types of cancer, including PC.[@CIT0005] It has been found that miR-455-3p plays an important role in many tumors, such as colorectal cancer, esophageal cancer, lung cancer, breast cancer, and melanoma.[@CIT0006]--[@CIT0010] Our previous studies have found that miR-455-3p is downregulated in PC and is involved in regulating proliferation and drug resistance by targeting TAZ.[@CIT0011] Transcriptional co-activator with PDZ-binding motif (TAZ), also known as WW domain-containing transcriptional regulator 1, is a transcriptional activator pervasively induced in several human tumors.[@CIT0012] The expression of TAZ has been found to be increased in many human tumors, and TAZ has been shown to be essential for cancer initiation, progression, and metastasis.[@CIT0013] Given that miR-455-3p can inhibit the expression of TAZ, which is considered to be an oncogene, we infer that miR-455-3p may function as a tumor suppressor via TAZ.

The Wnt signaling pathway is a highly conserved signaling pathway closely related to cell proliferation and differentiation.[@CIT0014] Activated β-catenin, Cyclin D and C-myc are involved in Wnt/β-catenin signaling.[@CIT0015] It has a wide range of biological effects and plays an important role in regulating most biological phenomena, such as ontogenesis, cell differentiation and apoptosis.[@CIT0016] Some studies have found that β-catenin can activate TAZ by binding to β-catenin and TBX5, and some studies have also found that polymerase activity inhibitors can inhibit the activation of TAZ through the Wnt signaling pathway.[@CIT0017] Melucci et al found TAZ and Wnt-related biomarkers may predict clinical outcomes in gastric cancer patients treated with chemotherapy,[@CIT0018] although the role of TAZ/Wnt/β-catenin signaling in PC still remains unknown.

This study aimed to further explore the function of miR-455-3p in human cells and whether it can restrain Wnt/β-catenin signaling via TAZ in pancreatic cancer.

Materials and Methods {#S0002}
=====================

Cell Lines and Cell Culture {#S0002-S2001}
---------------------------

Human pancreatic cancer cell lines PANC-1 and MIAPaCa-2 were provided by the Cell Bank of Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). They were cultured in DMEM (Gibco, USA) supplemented with 10% fetal bovine serum (NQBB, USA), 100 mg/mL streptomycin, and 100 IU/mL penicillin (Thermo Fisher Scientific, USA). Cells were incubated in a humidified incubator at 37°C with 5% CO~2.~

Cell Transfection {#S0002-S2002}
-----------------

Hsa-miR-455-3p mimics (sense: 50-GCAGUCCAUGGGCAUAUACAC-30; antisense: 50-GUAUAUGCCCAUGGACUGCUU-30), hsa-miR-455-3p inhibitors (sense: 50-GUGUAUAUGCCCAUGGACUGC-30), hsa-miR mimics NC (sense: 50-UUCUCCGAACGUGUCACGUTT-30; antisense: 50-ACGUGACACGUUCGGAGAATT-30), and hsa-miR inhibitors NC (50-CAGUACUUUUGUGUAGUACAA-30) were synthesized by Genepharma (Shanghai, China).PANC-1 and MIA paCa2 cells were transfected with miR-455-3p mimics (40 nM), miR-455-3p inhibitors (80 nM), or their NC using Lipofectamine 2000 (Invitrogen, USA), according to the manufacturer's instructions. The TAZ lentiviral expression vector (lenti-TAZ) were constructed by Shanghai GeneChem (Shanghai, China). The lentiviruses were transfected according to the manufacturer's instructions.

Analysis of Cell Apoptosis {#S0002-S2003}
--------------------------

Pancreatic cancer cells were transfected in 6-well plates. After incubation for 48 hrs, the cells were stained using the Annexin V-PE Detection Kit (BD Biosciences, USA), according to the manufacturer's protocols. All the samples were analyzed using the FACS Caliber II Sorter and Cell Quest FACS System (BD Biosciences, USA).

Total RNA Extaction and qPCR Analysis {#S0002-S2004}
-------------------------------------

Total RNA from tissues and cell lines was extracted using TRIzol Reagent (Invitrogen, USA), and subsequent synthesis of cDNA was carried out according to the manufacturer's protocols (TOYOBO, Japan). To evaluate TAZ mRNA levels, the reverse transcription products were analyzed using UltraSYBR Mixture (ComWin Biotech, China) on an ABI StepOne Plus qPCR System (Applied Biosystems, USA). GAPDH mRNA was used as an endogenous control. The expression level of miR-455-3p was evaluated using the same qPCR system. Endogenous U6 small nuclear RNA (snRNA) was used for normalization. The primers for amplifification were as follows: Actin (sense: 50 -CATGTACGTTGCTATCCAGGC-30; antisense: 50 -CTCCTTAATGTCACGCACGAT-30); Bcl (sense: 50 -CTTTGAGTTCGGTGGGGTCA-30; antisense: 50 -GGGCCGTACAGTTCCACAAA-30); Bax (sense: 50 -CATGGGCTGGACATTGGACT-30; antisense: 50 -AAAGTAGGAGAGGAGGCCGT); Caspase3 (sense: 50 -CGGCGCTCTGGTTTTCGTTA-30; antisense: 50-CCGAGA TGTCATTCCAGT GCT); E-Cadherin (sense: 50 -GCTGGACCGAGAGAGTTTCC-30; antisense: 50 -CAAAATCCAAGCCCGTGGTG-30); N-Cadherin (sense: 50 -TGGGAAATGGAAACTTGATGGC-30; antisense: 50 -TGGAAAGCTTCTCACGGCAT); Snail (sense: 50 -AAGATGCACATC CGAAGCCA-30; antisense: 50 -CATTCGGGAGAAGGTCCGAG); β-catenin(sense: 50 -CTGAGGAGCAGCTTCAGTCC-30; antisense: 50 -GGCCATGTCCAACTCCATCA-30); Cyclin D1 (sense: 50 -CCTTGTGGAGCCGGAGC-30; antisense: 50-CACTGGGCCGA AGAGGC); C-Myc (sense: 50 -GCAATGCGTTGCTGGGTTAT-30; antisense: 50 -CGCATCCTTGTCCTGTGAGT); The 2^−ΔΔ^CT method was used to calculate changes in miRNA expression levels.

Western Blot Analysis {#S0002-S2005}
---------------------

Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer containing protease inhibitors (Beyotime, Shanghai, China), and the protein concentration was measured using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, USA). Soluble lysate was mixed with loading buffer and boiled for 10 min. Proteins were separated by 10% SDS-PAGE, transferred to NC membranes, and then incubated with primary antibodies against Bcl-2 (1:1000, abcam, USA),Bax(1:1000, abcam), caspase-3(1:1000, abcam), E-cadherin (1:1000, CST, Danvers, MA), N-cadherin (1:1000, CST), snail (1:1000, CST), β-Catenin(1:1000, abcam), c-Myc(1:1000, abcam), Cyclin D1(1:1000, abcam) and β-actin (1:1000, Santa Cruz, Delaware, CA) overnight at 4°C. The membranes were further incubated with secondary antibodies (LI-COR Biosciences, USA) for 1 hr at 37°C, and the protein levels were detected by the enhanced chemiluminescence (ECL) Western Blot Analysis Detection System (Amersham, USA).

Wound Healing Assay {#S0002-S2006}
-------------------

Pancreatic cancer cells were transfected in 6-well plates and grown to monolayer confluency. Straight wounds were created in the cell monolayers using a sterile pipette tip. In order to remove the detached cells, the plates were washed twice using phosphate-buffered saline. Cells were then cultured in medium without fetal bovine serum at 37°C. Progression of migration was observed and photographed 24 hrs after wounding. Three random fields were captured and measured for each well.

Transwell Assay {#S0002-S2007}
---------------

Transwell chambers with a pore size of 8 µm and precoated with Matrigel (BD Biosciences, San Jose, CA, USA) were used to determine cells' invasion ability. Cells h(5 × 10^4^) were seeded into the upper chambers with 200 μL serum-free medium, and the lower chambers were filled with culture medium containing 10% fetal bovine serum. After 24 hrs of incubation, cells that failed to invade the membrane were removed gently with cotton swabs, while the invaded cells on the bottom were fixed with 4% formaldehyde for 20 min and stained with 0.1% crystal violet for 30 min before being photographed under a microscope (OLYMPUScx31, TOKYO, Japan). Five visual fields were randomly chosen and imaged.

Statistical Analysis {#S0002-S2008}
--------------------

All statistical analyses were conducted using SPSS software and illustration data were performed by GraphPad Prism. The statistical significance was evaluated using Student's *t*-test or one-way ANOVA and is presented as the mean ± SD; p \< 0.05 was considered statistically significant.

Results {#S0003}
=======

miR-455-3p Contributes to Apoptosis of PC Cells {#S0003-S2001}
-----------------------------------------------

Having observed that miR-455-3p is downregulated in PC and participates in regulating the proliferation of PC cells,[@CIT0011] we went on functionally characterizing miR-455-3p by studying its impact on PC cell apoptosis. PANC-1 and MIAPaCa-2 cells were transfected with miR-455-3p mimics, miR-455-3p inhibitors or their negative control. Flow cytometry was used to detect cell apoptosis, and we demonstrated that overexpression of miR-455-3p increased the number of apoptotic cells in both PANC1 and MIAPaCa2, and inhibition of miR-455-3p reduced the number of apoptotic cells ([Figure 1A](#F0001){ref-type="fig"} and [B](#F0001){ref-type="fig"}). To further explore the effect of miR-455-3p on apoptosis of pancreatic cancer cells, we detected the expression of apoptosis-related gene Bcl-2, Bax and Caspase-3 by qPCR and Western blotting. The results showed that overexpression of miR-455-3p increased the expression of Bcl-2 and decreased the expression of Bax and Caspase-3, whereas inhibition of miR-455-3p had the opposite effect ([Figure 1C](#F0001){ref-type="fig"}--[F](#F0001){ref-type="fig"}). These data indicate that miR-455-3p promotes apoptosis of PC cells by regulating apoptosis-related proteins.Figure 1MiR-455-3p contributes to apoptosis in pancreatic cancer cell lines. (**A, B**) Flow cytometry assessment of apoptosis in PANC1 and MIAPaCa2 cells transfected with miR-455-3p mimics or inhibitors. The total events shown in the lower right-hand and upper right-hand quadrants are apoptotic cells. (**C, D**) qPCR analysis of the mRNA expression of Bcl-2,Bax and Caspase-3 in pancreatic cancer cells transfected with miR-455-3p mimics or inhibitors. (**E, F**) Expression of Bcl-2, Bax and Caspase-3 in pancreatic cancer cells transfected with miR-455-3p mimics or inhibitors was detected by Western Blot. β-actin is used as loading control. All data are presented as the mean ± SD. \*p\<0.05, \*\*p \< 0.01, miR-455-3p mimics vs mimic control group, miR-455-3p inhibitors vs inhibitors control group.

miR-455-3p Inhibits the EMT-Mediated Metastasis of PC Cells {#S0003-S2002}
-----------------------------------------------------------

Wound healing assay and Transwell assay were carried out to investigate the effect of miR-455-3p on metastasis of pancreatic cancer. Similarly, PANC-1 and MIAPaCa-2 cells were transfected with miR-455-3p mimics, miR-455-3p inhibitors or their negative control. Wound healing assays demonstrated that overexpression of miR-455-3p significantly weakened migratory capability, while the inhibition of miR-455-3p enhanced the migratory capability of PANC-1 and MIAPaCa-2 cells ([Figure 2A](#F0002){ref-type="fig"} and [B](#F0002){ref-type="fig"}). The Matrigel invasion assay results showed the same trend: overexpression of miR-455-3p reduced the capacity of cell invasion and the inhibition of miR-455-3p increased the capacity of cell invasion ([Figure 2C](#F0002){ref-type="fig"} and [D](#F0002){ref-type="fig"}). In order to investigate whether miR-455-3p is involved in EMT-mediated metastasis, we performed qPCR and Western blotting to detect the expression of EMT-related proteins E-cadherin, N-cadherin and snail in PC cells. The results show that overexpression of miR-455-3p increased the expression of E-cadherin but decreased that of N-cadherin and snail. Conversely, the inhibition of miR-455-3p decreased the expression of E-cadherin but increased that of N-cadherin and snail ([Figure 2E](#F0002){ref-type="fig"}--[H](#F0002){ref-type="fig"}). These results support the conclusion that miR-455-3p suppresses the metastasis of PC by mediating EMT.Figure 2MiR-455-3p inhibits EMT-mediated metastasis in pancreatic cancer cells. (**A, B**) Wound healing assays of PANC-1 and MIAPaCa-2 after transfection with miR-455-3p mimics or inhibitors. Representative images depict the beginning (t = 0 h) and end (t = 24 h) of the recording. (**C, D**) Transwell assay of PANC-1 and MIAPaCa-2 cells transfected with miR-455-3p mimics or inhibitors. Cell invasion was analyzed 24 h after seeding in Transwells. (**E, F**) qPCR analysis of the mRNA expression of E-cadherin, N-cadherin and Snail in PANC1 and MIAPaCa2 cells transfected with miR-455-3p mimics or inhibitors. (**G, H**)Western blot analysis of the protein levels of E-cadherin, N-cadherin and Snail in PANC1 and MIAPaCa2 cells transfected with miR-455-3p mimics or inhibitors. β-actin is used as loading control. All data are presented as the mean ± SD. \*p \<0.05, \*\*p \<0.01, \*\*\*p \< 0.001, miR-455-3 p mimics vs mimic control group, miR-455-3p inhibitors vs inhibitors control group.

miR-455-3p Functions as a Tumor Suppressor via Targeting of TAZ {#S0003-S2003}
---------------------------------------------------------------

Our previous studies have confirmed that TAZ is a new direct downstream target of miR-455-3p,[@CIT0011] but whether miR-455-3p can exert its anti-cancer effect by targeting TAZ is still unclear. Thus, we detected cell apoptosis and EMT-mediated metastasis of PC cells, which were transfected with miR-455-3p mimics or miR-455-3p mimics plus TAZ expression vector. We confirmed that overexpression of miR-455-3 promoted apoptosis and inhibited migration, invasion and EMT in both PANC-1 and MIAPaCa-2 cells, whereas overexpression of TAZ reversed the anti-cancer effect of miR-455-3p ([Figure 3A](#F0003){ref-type="fig"}--[N](#F0003){ref-type="fig"}). Taken together, these data clearly suggest that miR-455-3p is not only involved in the proliferation and drug resistance of PC, but is also closely related to apoptosis, migration, invasion and EMT via targeting of TAZ.Figure 3MiR-455-3p participates in cell apoptosis, migration, invasion and EMT via targeting TAZ. (**A, B**) Flow cytometry assessment of apoptosis in PANC1 and MIAPaCa2 cells transfected with miR-455-3p mimic or miR-455-3p mimic plus TAZ expression vector. (**C, D**) Expression of Bcl-2, Bax and Caspase-3 in pancreatic cancer cells transfected with miR-455-3p mimic or miR-455-3p mimic plus TAZ expression vector was detected by qPCR. (**E, F**) Western blot analysis of Bcl-2,Bax and Caspase-3 in PANC1 and MIAPaCa2 cells transfected with miR-455-3p mimic or miR-455-3p mimic plus TAZ expression vector. β-actin is used as loading control. (**G, H**) The wound healing assay of PANC1 and MIAPaCa2 cells transfected with miR-455-3p mimic or miR-455-3p mimic plus TAZ expression vector. (**I, J**) The Transwell assay of PANC1 and MIAPaCa2 cells transfected with miR-455-3p mimic or miR-455-3p mimic plus TAZ expression vector. (**K, L**) Expression of E-cadherin, N-cadherin and Snail in pancreatic cancer cells transfected with miR-455-3p mimic or miR-455-3p mimic plus TAZ expression vector was detected by qPCR. (**M, N**) Western blot analysis of the protein levels of E-cadherin, N-cadherin and Snail in PANC1 and MIAPaCa2 cells transfected with miR-455-3p mimics or miR-455-3p mimic plus TAZ expression vector. β-actin is used as loading control. All data are presented as the mean ± SD. \*p \<0.05, \*\*p \< 0.01, \*\*\* p \< 0.001 ?miR-455-3p mimics vs mimic control group, miR-455-3p mimics vs miR-455-3p mimics+TAZ group.

miR-455-3p Restrains Wnt/β-Catenin Signaling via TAZ {#S0003-S2004}
----------------------------------------------------

The Wnt/β-catenin signaling pathway is involved in the development and progression of many human cancers. Wnt/β-catenin signaling promotes tumor proliferation and progression by activating the downstream genes β-catenin, Cyclin D and C-myc.[@CIT0015] To determine whether miR-455-3p acts as a tumor suppressor by restraining Wnt signaling via TAZ in PC, β-catenin, Cyclin D and C-myc were analyzed in PC cells transfected with miR-455-3p mimics or miR-455-3p mimics plus TAZ expression vector. As shown in [Figure 4](#F0004){ref-type="fig"}, overexpression of miR-455-3p suppressed the endogenous expression of β-catenin, Cyclin D and C-myc, but when cells were transfected with miR-455-3p mimics plus TAZ expression vector, the inhibitory effect of miR-455-3p failed to be exhibited. Together, these results demonstrated that miR-455-3p promotes apoptosis and suppresses migration, invasion and EMT by targeting TAZ and consequently deactivating the Wnt/β-catenin signaling in PC.Figure 4miR-455-3p restrains Wnt/β-catenin signaling via TAZ. (**A, B**) Expression of β-catenin, Cyclin D and C-myc in pancreatic cancer cells transfected with miR-455-3p mimic or miR-455-3p mimic plus TAZ expression vector was detected by qPCR. (**C, D**) Western blot analysis of β-catenin, Cyclin D and C-myc in PANC1 and MIAPaCa2 cells transfected with miR-455-3p mimic or miR-455-3p mimic plus TAZ expression vector β-actin is used as loading control vs miR-455-3p mimics/mimic control group, miR-455-3p mimics/miR-455-3p mimics+TAZ group. \*p \<0.05, miR-455-3p mimics vs mimic control group, miR-455-3p inhibitors vs inhibitors control group.

Discussion {#S0004}
==========

Micro-RNAs (miRNAs) are noncoding, single-stranded RNAs of around 22 nucleotides involved in the pathogenic mechanisms of carcinogenesis and metastasis.[@CIT0019] Based on the different genes targeted by different miRNAs in various types of cells, miRNAs may function as either oncogenes or tumor suppressors.[@CIT0020] Recently, the roles of miRNAs in the progression of PC are becoming recognized and a lot of work has focused on understanding how miRNAs regulate target genes in PC initiation, progression, metastasis, and relapse in addition to drug response and resistance in order to improve diagnosis, predict prognosis, and develop new therapeutic strategies.[@CIT0021] MicroRNA-455 is a family of miRNAs that are strongly associated with many biological processes.[@CIT0022]--[@CIT0026] Specifically, accumulating evidence suggests that miR-455-3p acts as a tumor suppressor in several cancers including colorectal cancer, esophageal cancer, lung cancer, breast cancer and melanoma,[@CIT0006]--[@CIT0010] suggesting that miR-455-3p might exert important effects on PC. Our previous studies have found that miR-455-3p is down-regulated in pancreatic cancer and is involved in regulating proliferation and drug resistance via targeting TAZ. However, the other functions associated with cancer progression and the potential mechanism of miR-455-3p in pancreatic cancer have not been explored.

In this study, we demonstrated that miR-455-3p contributes to cell apoptosis and inhibits cell migration, invasion and EMT in PC by directly suppressing TAZ expression and consequently inactivating Wnt/β-catenin signaling. We used flow cytometry to identify the effect on cell apoptosis in PC cells. The results showed that miR-455-3p overexpression prompted apoptosis and inhibited migration, invasion and EMT of PC cells, whereas miR-455-3p downregulation significantly inhibited cell apoptosis and prompted migration, invasion and EMT in both PANC-1 and MIAPaCa-2 cells. Furthermore, qPCR and Western Blot Analysis demonstrated that miR-455-3p promotes the apoptosis of pancreatic cancer cells by regulating apoptosis-related proteins Bcl-2, Bax and Caspase-3. An analysis of wound healing assay and Transwell assay revealed that miR-455-3p suppressed migration and invasion in pancreatic cancer cells. EMT is a biological process that plays a key role in the progression of many cancers, including in metastasis.[@CIT0027] Our research confirmed that miR-455-3p suppressed the EMT of PC. These data indicate that miR-455-3p functions as a tumor suppressor in PC.

TAZ is an important functional component of the Hippo pathway, a pathway associated with tumorigenesis.[@CIT0028] It has been widely accepted that TAZ acts as a potent oncogene in multiple cell types, including PC.[@CIT0029] In this paper, by transfecting pancreatic cancer cells with miR-455-3p mimics or miR-455-3p mimics plus TAZ expression vector, we confirmed that miR-455-3p exerts its anti-cancer effect through TAZ. The Wnt/β-catenin pathway has long been associated with tumorigenesis, tumor plasticity, and cancer stem cells, and high expression levels of the Wnt pathway has been associated with poor survival rates.[@CIT0030] Moreover, some studies have demonstrated that Wnt signaling is closely related to TAZ.[@CIT0017],[@CIT0018],[@CIT0031] β-catenin is a main member of the Wnt signaling pathway, and Cyclin D and C-myc are the major downstream effectors of this pathway.[@CIT0032] Therefore, we examined the expression of β-catenin, Cyclin D and C-myc. We found that overexpression of miR-455-3p suppressed β-catenin, Cyclin D and C-myc in cells, and TAZ reversed the inhibitory effect of miR-455-3p on the Wnt pathway. These findings suggest that miR-455-3p functions as a tumor suppressor by restraining Wnt/β-catenin signaling via TAZ in PC.

In summary, we provide convincing evidence that miR-455-3p directly targets TAZ to regulate cell apoptosis, migration, invasion and EMT in PC. Additionally,our study elucidates a novel mechanism by which miR-455-3p suppresses PC development by deactivating Wnt/β-catenin signaling via TAZ. We suggest that these findings may provide a promising target in the treatment of PC.
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